Barchart on Facebook
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

West Pharmaceutical Services (WST)

West Pharmaceutical Services (WST)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 20,817,994
  • Shares Outstanding, K 73,841
  • Annual Sales, $ 1,840 M
  • Annual Income, $ 241,700 K
  • 60-Month Beta 1.13
  • Price/Sales 11.21
  • Price/Cash Flow 59.41
  • Price/Book 12.84
Trade WST with:

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/20
See More
  • Average Estimate 1.09
  • Number of Estimates 3
  • High Estimate 1.18
  • Low Estimate 0.97
  • Prior Year 0.82
  • Growth Rate Est. (year over year) +32.93%

Price Performance

See More
Period Period Low Period High Performance
1-Month
261.05 +8.00%
on 09/25/20
303.14 -7.00%
on 10/13/20
+13.63 (+5.08%)
since 09/23/20
3-Month
253.75 +11.11%
on 07/24/20
303.14 -7.00%
on 10/13/20
+19.87 (+7.58%)
since 07/23/20
52-Week
124.53 +126.40%
on 03/23/20
303.14 -7.00%
on 10/13/20
+142.76 (+102.58%)
since 10/23/19

Most Recent Stories

More News
West Launches New Vial2Bag Advanced™ 20mm Admixture Device

, /PRNewswire/ --  (NYSE: WST), West Pharmaceutical Services, Inc. (West) is pleased to announce FDA 510(k) clearance and launch of its Vial2Bag Advanced™ 20mm Admixture Device.

WST : 281.93 (+0.90%)
Shares of WST Up 28.6% Since Uptrend Call on Shares

SmarTrend identified an Uptrend for West Pharmaceut (NYSE:WST) on June 23rd, 2020 at $219.24. In approximately 4 months, West Pharmaceut has returned 28.63% as of today's recent price of $282.00.

WST : 281.93 (+0.90%)
West Pharmaceut Set to Possibly Rebound After Yesterday's Selloff of 1.42%

West Pharmaceut (NYSE:WST) traded in a range yesterday that spanned from a low of $279.28 to a high of $286.72. Yesterday, the shares fell 1.4%, which took the trading range below the 3-day low of $280.06...

WST : 281.93 (+0.90%)
West Pharmaceutical Services (WST) Q3 Earnings and Revenues Top Estimates

West Pharmaceutical (WST) delivered earnings and revenue surprises of 13.86% and 7.20%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?

WST : 281.93 (+0.90%)
West Pharmaceutical: 3Q Earnings Snapshot

EXTON, Pa. (AP) _ West Pharmaceutical Services Inc. (WST) on Thursday reported third-quarter net income of $82.3 million.

WST : 281.93 (+0.90%)
West Announces Third-Quarter 2020 Results

, /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the third-quarter 2020 and updated full-year 2020 financial guidance.

WST : 281.93 (+0.90%)
West Pharmaceutical Services (WST) Earnings Expected to Grow: Should You Buy?

West Pharmaceutical (WST) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

WST : 281.93 (+0.90%)
West Pharmaceut Shares Up 36.3% Since SmarTrend's Buy Recommendation (WST)

SmarTrend identified an Uptrend for West Pharmaceut (NYSE:WST) on June 23rd, 2020 at $219.24. In approximately 4 months, West Pharmaceut has returned 36.31% as of today's recent price of $298.84.

WST : 281.93 (+0.90%)
After Yesterday's Decline of 3.02%, West Pharmaceut Offers Investors Better Value

West Pharmaceut (NYSE:WST) traded in a range yesterday that spanned from a low of $289.83 to a high of $299.03. Yesterday, the shares fell 3.0%, which took the trading range below the 3-day low of $292.42...

WST : 281.93 (+0.90%)
MCK or WST: Which Is the Better Value Stock Right Now?

MCK vs. WST: Which Stock Is the Better Value Option?

MCK : 156.41 (+1.41%)
WST : 281.93 (+0.90%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

West Pharmaceutical Services, Inc. is a global drug delivery technology company that applies proprietary materials science, formulation research and manufacturing innovation to advance the quality, therapeutic value, development speed and rapid market availability of pharmaceuticals, biologics, vaccines...

See More

Key Turning Points

2nd Resistance Point 286.16
1st Resistance Point 284.04
Last Price 281.93
1st Support Level 278.55
2nd Support Level 275.18

See More

52-Week High 303.14
Last Price 281.93
Fibonacci 61.8% 234.91
Fibonacci 50% 213.84
Fibonacci 38.2% 192.76
52-Week Low 124.53

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar